Early discontinuation of endocrine therapy for breast cancer: Who is at risk in clinical practice?
Purpose: Despite evidence supporting at least five years of endocrine therapy for early breast cancer, many women discontinue therapy early. We investigated the impact of initial therapy type and specific comorbidities on discontinuation of endocrine therapy in clinical practice. Methods: We identif...
| Main Authors: | Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Malacova, Eva, Roughead, E. |
|---|---|
| Format: | Journal Article |
| Published: |
SpringerOpen
2014
|
| Online Access: | http://hdl.handle.net/20.500.11937/55821 |
Similar Items
HALF OF WOMEN WITH EARLY BREAST CANCER STOP ENDOCRINE THERAPY BEFORE FIVE YEARS: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY
by: Kemp, A., et al.
Published: (2014)
by: Kemp, A., et al.
Published: (2014)
Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice
by: Kemp, A., et al.
Published: (2014)
by: Kemp, A., et al.
Published: (2014)
Development of a clinically relevant subclassification of luminal breast cancer related to response to endocrine therapy
by: Alfarsi, Lutfi
Published: (2020)
by: Alfarsi, Lutfi
Published: (2020)
Endocrine therapy for breast cancer: a model of hormonal manipulation
by: Johnston, Simon J., et al.
Published: (2018)
by: Johnston, Simon J., et al.
Published: (2018)
Optimising endocrine therapy in postmenopausal women with advanced breast cancer
by: Yau, Thomas Ho Lai, et al.
Published: (2018)
by: Yau, Thomas Ho Lai, et al.
Published: (2018)
Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer
by: Alfarsi, Lutfi, et al.
Published: (2018)
by: Alfarsi, Lutfi, et al.
Published: (2018)
Investigating extracellular vesicle communication in the endocrine cancers of the prostate and breast
by: Brown, Thomas J.
Published: (2024)
by: Brown, Thomas J.
Published: (2024)
Cost-effectiveness of primary endocrine therapy comparing against surgery as the initial treatment strategy in older women with primary breast cancer
by: Mousa, Rimal
Published: (2017)
by: Mousa, Rimal
Published: (2017)
Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: a structural approach
by: Etti, Imaobong C., et al.
Published: (2024)
by: Etti, Imaobong C., et al.
Published: (2024)
In vitro fertilization and breast cancer: Is there cause for concern?
by: Stewart, L., et al.
Published: (2012)
by: Stewart, L., et al.
Published: (2012)
Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer
by: Wolff, A., et al.
Published: (2013)
by: Wolff, A., et al.
Published: (2013)
Lifetime physical activity and risk of breast cancer in pre-and post-menopausal women
by: Si, Si, et al.
Published: (2015)
by: Si, Si, et al.
Published: (2015)
Long-term risk of ectopic pregnancy varies by method of tubal sterilization: A whole-population study
by: Malacova, Eva, et al.
Published: (2014)
by: Malacova, Eva, et al.
Published: (2014)
PEG-PLA Nanoformulation for Breast Cancer Therapy
by: Kannapiran, Sushma, et al.
Published: (2022)
by: Kannapiran, Sushma, et al.
Published: (2022)
Have increases in co-payments for medicines further burdened Australians in remote and disadvantaged areas?
by: Kemp, A., et al.
Published: (2012)
by: Kemp, A., et al.
Published: (2012)
From the city to the bush: Increases in patient co-payments for medicines have impacted on medicine use across Australia
by: Kemp, A., et al.
Published: (2013)
by: Kemp, A., et al.
Published: (2013)
Heightened perception of breast cancer risk in young women at risk of familial breast cancer
by: Glassey, R., et al.
Published: (2017)
by: Glassey, R., et al.
Published: (2017)
Endocrine and immune responses to resistance training in prostate cancer patients
by: Galvao, D, et al.
Published: (2008)
by: Galvao, D, et al.
Published: (2008)
Deciphering invasive breast cancer heterogeneity for personalised therapy
by: Althobiti, Maryam
Published: (2021)
by: Althobiti, Maryam
Published: (2021)
Advancing the clinical implementation of Clostridial cancer therapies
by: Zygouropoulou, Maria
Published: (2019)
by: Zygouropoulou, Maria
Published: (2019)
Effectiveness of in vitro fertilization in women with previous tubal sterilization
by: Malacova, Eva, et al.
Published: (2015)
by: Malacova, Eva, et al.
Published: (2015)
Occupational exposure to solvents and risk of breast cancer
by: Glass, D., et al.
Published: (2015)
by: Glass, D., et al.
Published: (2015)
Simulation on transdermal patch for breast cancer therapy by using COMSOL
by: Tan, Ming Sien
Published: (2010)
by: Tan, Ming Sien
Published: (2010)
Biology and clinical outcomes of early primary breast cancer in older women: a study based on core needle biopsy
by: Albanghali, Mohammad
Published: (2016)
by: Albanghali, Mohammad
Published: (2016)
The role of the breast care nurse during treatment for early breast cancer: the patient's perspective.
by: Halkett, Georgia
Published: (2006)
by: Halkett, Georgia
Published: (2006)
A UWB imaging system to detect early breast cancer in heterogeneous breast phantom
by: Saleh, Alshehri, et al.
Published: (2011)
by: Saleh, Alshehri, et al.
Published: (2011)
A UWB imaging system to detect early breast cancer in heterogeneous breast phantom
by: Alshehri, Saleh Ali, et al.
Published: (2011)
by: Alshehri, Saleh Ali, et al.
Published: (2011)
Controversial issues in the management of older adults with early breast cancer
by: Mislang, Anna Rachelle, et al.
Published: (2017)
by: Mislang, Anna Rachelle, et al.
Published: (2017)
The phenomenon of making decisions during the experience of early breast cancer
by: Halkett, Georgia, et al.
Published: (2007)
by: Halkett, Georgia, et al.
Published: (2007)
The breast cancer patient's experience of making radiation therapy treatment decisions
by: Halkett, Georgia, et al.
Published: (2005)
by: Halkett, Georgia, et al.
Published: (2005)
Potential role of targeted therapies in the treatment of triple-negative breast cancer
by: Jia, L., et al.
Published: (2016)
by: Jia, L., et al.
Published: (2016)
Oestrogen receptor negative early operable primary breast cancer in older women—biological characteristics and long-term clinical outcome
by: Coleman, William B., et al.
Published: (2017)
by: Coleman, William B., et al.
Published: (2017)
Endocrine control of oogenesis in teleosts
by: Fard, Ehsan Ramezani, et al.
Published: (2013)
by: Fard, Ehsan Ramezani, et al.
Published: (2013)
Safety and clinical usage of Newcastle disease virus in cancer therapy.
by: Lam, Han Yuen, et al.
Published: (2011)
by: Lam, Han Yuen, et al.
Published: (2011)
Breast conserving therapy versus mastectomy in young breast cancer patients in asian settings / Siamala Sinnadurai
by: Siamala, Sinnadurai
Published: (2018)
by: Siamala, Sinnadurai
Published: (2018)
Breast cancer prognostic classifiers: combining clinical with molecular profiles
by: Muftah, Abir A. Abdelhadi
Published: (2017)
by: Muftah, Abir A. Abdelhadi
Published: (2017)
Trastuzumab biosimilar in early breast cancer setting: Will there be direct patient benefits?
by: Chan, Arlene
Published: (2017)
by: Chan, Arlene
Published: (2017)
Patterns of surgical treatment for women diagnosed with early breast cancer in Queensland
by: Thompson, B., et al.
Published: (2008)
by: Thompson, B., et al.
Published: (2008)
Artificial neural networks in image processing for early detection of breast cancer
by: Mehdy, Mehdy Mwaffeq, et al.
Published: (2017)
by: Mehdy, Mehdy Mwaffeq, et al.
Published: (2017)
Women's beliefs about breast cancer causation in a breast cancer case-control study
by: Lizama, N., et al.
Published: (2015)
by: Lizama, N., et al.
Published: (2015)
Similar Items
-
HALF OF WOMEN WITH EARLY BREAST CANCER STOP ENDOCRINE THERAPY BEFORE FIVE YEARS: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY
by: Kemp, A., et al.
Published: (2014) -
Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice
by: Kemp, A., et al.
Published: (2014) -
Development of a clinically relevant subclassification of luminal breast cancer related to response to endocrine therapy
by: Alfarsi, Lutfi
Published: (2020) -
Endocrine therapy for breast cancer: a model of hormonal manipulation
by: Johnston, Simon J., et al.
Published: (2018) -
Optimising endocrine therapy in postmenopausal women with advanced breast cancer
by: Yau, Thomas Ho Lai, et al.
Published: (2018)